• 검색 결과가 없습니다.

Non-alcoholic fatty liver disease in polycystic ovary syndrome women

N/A
N/A
Protected

Academic year: 2021

Share "Non-alcoholic fatty liver disease in polycystic ovary syndrome women"

Copied!
11
0
0

로드 중.... (전체 텍스트 보기)

전체 글

Loading

수치

Table 1.   Baseline characteristics of PCOS women according to subsequent NAFLD occurrence
Table 2.   Baseline characteristics according to the age of PCOS diagnosis. Values are shown as median
Figure 2.  Metabolic syndrome at the time of polycystic ovary syndrome (PCOS) diagnosis in non-alcoholic
Table 3.   Univariate analysis of variables associated with NAFLD development in PCOS patients
+3

참조

관련 문서

Effect of caloric restriction on the expression of PGC-1 and PPARs mRNA in liver of Otsuka Long-Evans Tokushima Fatty Rats.. Long-lived growth hormone

Serum uric acid levels and risk for vascular disease in patients with metabolic syndrome... Prevalence if the metabolic syndrome in a Turkish

This study was conducted to analyze the effects of obesity on the core stability and metabolic syndrome risk factors of middle - aged women.. The effect

The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new‑onset type 2

Age at diagnosis after 30 years, baseline serum creatinine levels, and cyst infection are the independent risk factors for kidney failure, as found in this

1 reported the usefulness of the metabolic score for insulin resistance (METS-IR) in the screening and prediction of non- alcoholic fatty liver disease (NAFLD) in middle-aged

MAFLD, metabolic dysfunction-associated fatty liver disease; NAFLD, nonalcoholic fatty liver disease; CVD, cardiovascular disease; CI, confidence interval; Model 1,

cACLD = compensated advanced chronic liver disease, dACLD = decompensated advanced chronic liver disease, LS = liver stiffness, LS-SIR = liver-to-spleen signal intensity